AMISTAD, a new collections-based research project led by London’s Natural History Museum, is working on untangling the identities of a group of blue butterflies from South America.
Dyne Therapeutics, citing trial data, said it will ask the FDA to approve DYNE-251, its therapy for DMD amenable to exon 51 skipping.
Morning Overview on MSN
Scientists unveil a surprising new timeline for ancient Egypt
New scientific work is quietly redrawing the master timeline of ancient Egypt, shifting key dynasties and even the start of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback